Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Aptar Pharma CPS Intranasal Delivery Device
DEVICE
2 trials
Sponsors
Wake Forest University Health Sciences
Conditions
Alzheimer Disease
Alzheimer Disease, Early Onset
Cognitive Impairment
Mild Cognitive Impairment
Phase 2
SNIFF - 3-Week Aptar CPS Device
Withdrawn
NCT05006599
Wake Forest University Health Sciences
Alzheimer Disease, Early Onset, Cognitive Impairment, Mild Cognitive Impairment
Start: 2025-05-31
End: 2031-05-31
Updated: 2025-07-28
SNIFF - Combo INI+EMPA Trial
Completed
NCT05081219
Wake Forest University Health Sciences
Alzheimer Disease, Cognitive Impairment, Mild Cognitive Impairment
Start: 2021-09-14
End: 2024-09-17
Updated: 2025-10-21
Related Papers
A phase 2A/B randomized trial of metabolic modulators intranasal insulin and empagliflozin for MCI and early AD.
2025-10-01
1 citations